Centrica PLC
02 October 2003
2 October 2003
Centrica plc
Directors' interests - Long Term Incentive Scheme (LTIS)
Centrica plc announces that on 1 October 2003, a total of 4,562,036 ordinary
Centrica shares of 5 5/9 pence each ('shares') in respect of awards made under
the terms of the LTIS in October 1998 were released from trust. These awards,
which were subject to performance conditions*, were released by the trustees of
the scheme to a number of participants, including the executive directors
detailed below, following the completion of the three-year performance period in
October 2001 and expiry of the required two-year retention period. On release,
participants are liable to pay income tax at their marginal rate and National
Insurance contributions at 1% on the value of the shares. Shares were sold at
185.22p on 1 October 2003 to satisfy this tax and NIC liability, and dealing
charges.
The specific details of the release and disposals relating to the executive
directors are as follows:
Executive director Shares Released Shares sold Net number of
shares transferred
Mark Clare 181,431 74,387 107,044
Sir Roy Gardner 340,716 139,694 201,022
Roger Wood 189,949 77,880 112,069
Allocations held by the above executive directors under the LTIS are reduced
accordingly to reflect this release.
Following the release and the subsequent tax-related transactions, the executive
directors' shareholdings (excluding remaining allocations held under the LTIS
and subject to conditions) are:
Executive director shares
Mark Clare 472,509
Sir Roy Gardner 2,359,969
Roger Wood 498,080
As a matter of policy, executive directors are expected to retain a minimum
holding of shares in the Company to the value of once times base salary. Each of
the three executive directors named above has achieved his minimum holding
requirement.
The total number of shares in issue as at 02 October 2003 is 4,265,242,374.
* The performance conditions are linked to the Company's total
shareholder return (TSR) relative to the returns of its FTSE 100 comparator
group. The maximum award only vests if the Company's TSR over the
performance period is ranked in 25th position or above of the 100 companies
in the LTIS comparator group. At the conclusion of the performance period on
30 September 2001, the Company was ranked in fourth position in the LTIS
comparator group.
Separately and in addition to the above, Centrica plc announces that on 2
October 2003, a total of 152,245 ordinary Centrica shares of 5 5/9 pence each in
Centrica plc were transferred from trust by the trustees of the Long Term
Incentive Scheme (LTIS) to participants of the LTIS. All shares were transferred
to former employees, in satisfaction of allocations which had completed their
respective performance periods before they left.
The executive directors of the Company have not received any shares pursuant to
this release but being beneficiaries under the LTIS, as with other Centrica
group employees, their potential interest in the shares held and transferred by
the trust has been reduced accordingly.
Enquiries: Media Relations 01753 494084
Investor Relations 01753 494900
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.